"castration resistant" trang 2 - tải miễn phí từ tailieunhanh
Real-world effectiveness of third-line cabazitaxel in patients with metastatic castration-resistant prostate cancer: CARD-like analysis of data from a post-marketing surveillance in Japan

Real-world effectiveness of third-line cabazitaxel in patients with metastatic castration-resistant prostate cancer: CARD-like analysis of data from a post-marketing surveillance in Japan
10    7    1
The combination of serum insulin, osteopontin, and hepatocyte growth factor predicts time to castration-resistant progression in androgen dependent metastatic prostate cancer- an exploratory study

The combination of serum insulin, osteopontin, and hepatocyte growth factor predicts time to castration-resistant progression in androgen dependent metastatic prostate cancer- an exploratory study
10    49    1
Quantitative analysis of castration resistant prostate cancer progression through phosphoproteome signaling

Quantitative analysis of castration resistant prostate cancer progression through phosphoproteome signaling
12    70    1
The efficacy and toxicity of cabazitaxel for treatment of docetaxel-resistant prostate cancer correlating with the initial doses in Japanese patients

The efficacy and toxicity of cabazitaxel for treatment of docetaxel-resistant prostate cancer correlating with the initial doses in Japanese patients
7    48    1
báo cáo khoa học:

báo cáo khoa học:" Pain in castration-resistant prostate cancer with bone metastases: a qualitative study"
11    40    0
Báo cáo y học:

Báo cáo y học: " Androgens as therapy for androgen receptorpositive castration-resistant prostate cancer"
12    34    0
báo cáo hóa học:

báo cáo hóa học:" Pain in castration-resistant prostate cancer with bone metastases: a qualitative study"
11    42    0
The effects and mechanism of YK-4-279 in combination with docetaxel on prostate cancer

The effects and mechanism of YK-4-279 in combination with docetaxel on prostate cancer
11    64    0
Interstitial pneumonitis in a castrationresistant prostate cancer patient receiving cabazitaxel after thoracic radiation therapy: A case report

Interstitial pneumonitis in a castrationresistant prostate cancer patient receiving cabazitaxel after thoracic radiation therapy: A case report
4    55    0
Intermediate PSA half-life after neoadjuvant hormone therapy predicts reduced risk of castration-resistant prostate cancer development after radical prostatectomy

Intermediate PSA half-life after neoadjuvant hormone therapy predicts reduced risk of castration-resistant prostate cancer development after radical prostatectomy
8    59    1
Enzalutamide versus abiraterone as a first-line endocrine therapy for castrationresistant prostate cancer (ENABLE study for PCa): A study protocol for a multicenter randomized phase III trial

Enzalutamide versus abiraterone as a first-line endocrine therapy for castrationresistant prostate cancer (ENABLE study for PCa): A study protocol for a multicenter randomized phase III trial
6    68    1
Abiraterone acetate plus prednisone for the Management of Metastatic CastrationResistant Prostate Cancer (mCRPC) without prior use of chemotherapy: Report from a large, international, real-world retrospective cohort study

Abiraterone acetate plus prednisone for the Management of Metastatic CastrationResistant Prostate Cancer (mCRPC) without prior use of chemotherapy: Report from a large, international, real-world retrospective cohort study
12    63    1
Epithelial cell adhesion molecule (EpCAM) is involved in prostate cancer chemotherapy/radiotherapy response in vivo

Epithelial cell adhesion molecule (EpCAM) is involved in prostate cancer chemotherapy/radiotherapy response in vivo
12    42    1
Cyproterone acetate enhances TRAILinduced androgen-independent prostate cancer cell apoptosis via up-regulation of death receptor 5

Cyproterone acetate enhances TRAILinduced androgen-independent prostate cancer cell apoptosis via up-regulation of death receptor 5
11    57    1
A phase II trial of personalized peptide vaccination in castration-resistant prostate cancer patients: Prolongation of prostate-specific antigen doubling time

A phase II trial of personalized peptide vaccination in castration-resistant prostate cancer patients: Prolongation of prostate-specific antigen doubling time
10    51    1
High testosterone levels in prostate tissue obtained by needle biopsy correlate with poor-prognosis factors in prostate cancer patients

High testosterone levels in prostate tissue obtained by needle biopsy correlate with poor-prognosis factors in prostate cancer patients
7    85    1
Towards targeted combinatorial therapy design for the treatment of castration-resistant prostate cancer

Towards targeted combinatorial therapy design for the treatment of castration-resistant prostate cancer
11    42    1
Cost-effectiveness analysis of cabazitaxel for metastatic castration resistant prostate cancer after docetaxel and androgensignaling-targeted inhibitor resistance

Cost-effectiveness analysis of cabazitaxel for metastatic castration resistant prostate cancer after docetaxel and androgensignaling-targeted inhibitor resistance
8    54    1
Integration of circulating tumor cell and neutrophil-lymphocyte ratio to identify high-risk metastatic castration-resistant prostate cancer patients

Integration of circulating tumor cell and neutrophil-lymphocyte ratio to identify high-risk metastatic castration-resistant prostate cancer patients
11    57    1
Corticosteroid switch from prednisone to dexamethasone in metastatic castrationresistant prostate cancer patients with biochemical progression on abiraterone acetate plus prednisone

Corticosteroid switch from prednisone to dexamethasone in metastatic castrationresistant prostate cancer patients with biochemical progression on abiraterone acetate plus prednisone
9    47    1